4-Hydroxybenzyl alcohol derivatives and their sedative-hypnotic activities.
Study Design
- Type d'étude
- animal study (preclinical)
- Intervention
- 4-Hydroxybenzyl alcohol derivatives and their sedative-hypnotic activities. 10 mg/kg (2FHBA)
- Comparateur
- Placebo
- Direction de l'effet
- Positive
- Risque de biais
- Unclear
Abstract
4-Hydroxybenzyl alcohol (HBA), one of the characteristic active components of Gastrodia elata, exhibits obvious effects on the human central nervous system. In order to acquire compounds with superior bioactivity, 10 derivatives of HBA were synthesized from HBA and carboxylic acids. The sedative effects of the 10 HBA derivatives were evaluated using a spontaneous locomotor activity test (SLT) in mice, and their hypnotic effects were determined to be synergistic with pentobarbital-induced sleep. The results showed that 4-hydroxybenzyl alcohol 3-furancarboxylic acid diester (2FHBA, 10 mg kg-1) exhibited the strongest sedative-hypnotic activity among HBA and its derivatives, and 2FHBA could reverse the insomnia caused by p-chlorophenylalanine (pCPA), flumazenil (FLU) and thiosemicarbazide (TSC). Meanwhile, 2FHBA and 5-hydroxytryptophan (5-HTP) showed a synergistic effect. The results suggested that 2FHBA might be a potential agent against insomnia, which might be mediated by the serotonergic and GABAergic systems.
Used In Evidence Reviews
Similar Papers
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
Sleep medicine reviews · 2011
A systematic review of insomnia and complementary medicine.
Alternative medicine review : a journal of clinical therapeutic · 1998
5-Hydroxytryptophan: a clinically-effective serotonin precursor.
Annual review of nutrition · 2021
Sleep and Diet: Mounting Evidence of a Cyclical Relationship.
Psychosomatic medicine · 1999
Dietary supplements and natural products as psychotherapeutic agents.
Drugs & aging · 2018